DMUC5754A
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DMUC5754A, covering 2016-11-02 to 2016-11-02. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Pharmacokinetics of DMUC5754A Administered Intravenously to Patients With Platinum-Resistant Ovarian Cancer or Unresectable Pancreatic Cancer [Phase 1]